Influence of D(-)CCP and (±)CPP upon the protective action of conventional antiepileptic drugs against electroconvulsions in mice

Polish Journal of Pharmacology

Volumn 52, Issue 6, 2000, Pages 431-439

  Borowicz, K K ^a   Kleinrok, Z ^a   Czuczwar, S J ^a  

^a INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Antiepileptic drugs; CPP; NMDA receptor; Seizures

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; 4 (2H TETRAZOL 5 YLMETHYL) 2 PIPERIDINECARBOXYLIC ACID; 4 (3 PHOSPHONOPROPENYL) 2 PIPERAZINECARBOXYLIC ACID; 4 (3 PHOSPHONOPROPYL) 2 PIPERAZINECARBOXYLIC ACID; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CARBOXYLIC ACID DERIVATIVE; DECAHYDRO 6 PHOSPHONOMETHYL 3 ISOQUINOLINECARBOXYLIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENOBARBITAL; PHENYTOIN; UNCLASSIFIED DRUG; VALPROIC ACID; 3-(2-CARBOXYPIPERAZIN-4-YL)PROPYL-1-PHOSPHONIC ACID; PIPERAZINE DERIVATIVE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; COGNITION; CONTROLLED STUDY; CONVULSION; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG COMPETITION; DRUG MECHANISM; DRUG POTENTIATION; ELECTRIC SHOCK; MALE; MOTOR DYSFUNCTION; MOUSE; NEUROPROTECTION; NONHUMAN; STEREOCHEMISTRY; ANIMAL; AVOIDANCE BEHAVIOR; DRUG EFFECT; DRUG INTERACTION; GRAND MAL EPILEPSY; MEMORY; PSYCHOMOTOR PERFORMANCE; SEIZURE; STEREOISOMERISM;

ANIMALS; ANTICONVULSANTS; AVOIDANCE LEARNING; DRUG INTERACTIONS; ELECTROSHOCK; EPILEPSY, TONIC-CLONIC; MALE; MEMORY; MICE; PIPERAZINES; PSYCHOMOTOR PERFORMANCE; RECEPTORS, N-METHYL-D-ASPARTATE; SEIZURES; STEREOISOMERISM;

EID: 0034352480     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Progress report on new antiepileptic drugs: A summary of the fourth Eilat conference
2. Une nouvelle méthode simple pour explorer l'action tranquillisante: Le test de la cheminée
3. Competitive NMDA-receptor antagonists, LY 235959 and LY 233053, enhance the protective efficacy of various antiepileptic drugs against maximal electroshock-induced seizures in mice
4. Ifenprodil and SL 820715 are antagonists at the polyamine site of N-methyl-D-aspartate (NMDA) receptor
5. Anticonvulsant action of excitatory amino acid antagonists
6. Competitive antagonists of NMDA receptors, CGP 37849 and CGP 39551, enhance the anticonvulsant activity of valproate against electroconvulsions in mice
7. Perspectives for the use of excitatory amino acid ionotropic receptor antagonists as antiepileptic drugs
8. Influence of combined treatment with NMDA and non-NMDA receptor antagonists on electroconvulsions in mice
9. Protection against chemically induced seizures by 2-amino-7-phosphonoheptanoic acid
10. LY 300164, a novel antagonist of AMPA/ kainate receptors, potentiates the anticonvulsive activity of antiepileptic drugs
11. Interactions of excitatory amino acid antagonists with conventional antiepileptic drugs
12. Interaction of calcium channel blockers and excitatory amino acid antagonists with conventional antiepileptic drugs
13. Effects of excitatory amino acid antagonists on the anticonvulsant action of phenobarbital or diphenylhydantoin in mice
14. 3H]D-AP5 binding sites on brain membranes and anticonvulsant activity
15. Excitatory amino acid receptors in epilepsy
16. Modulation of memory processing by glutamic acid receptor agonists and antagonists
17. Taking apart NMDA receptors
18. Epilepsy and the concentration of plasma amino acids in humans
19. 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex
20. Non-competitive antagonists of excitatory amino acid receptors
21. Properties of NMDA receptor channels in neurons acutely isolated from epileptic (kindled) rats
22. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: Characterization in vitro and in vivo
23. A simplified method of evaluating dose-effect experiments
24. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy: Comparison with MK-801 and carbamazepine
25. Excitatory amino acids in epilepsy and potential novel therapies
26. NMDA receptors of dentate gyrus granule cells participate in synaptic transmission following kindling
27. The excitatory amino acid receptors: Their classes, pharmacology, and distinct properties in the function of the central nervous system
28. Excitatory amino acid antagonists and memory: Effects of drugs acting at N-methyl-D-aspartate receptors in learning and memory
29. Glutamate in CNS disorders as a target for drug development: An update
30. Competitive NMDA receptor antagonists enhance the antielectroshock activity of various antiepileptics
31. The NMDA receptor, NMDA antagonists and epilepsy therapy
32. The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy
33. An NMDA-mediated component of excitatory synaptic input to dentate granule cells in "epileptic" Human hippocampus studied in vitro
34. Influence of MK-801 on the anticonvulsant activity of valproate against electroconvulsions in mice
35. NMDA-but not kainate-mediated events reduce efficacy of some antiepileptic drugs against generalized tonic-clonic seizures in mice
36. Benzodiazepines impair and beta-carbolines enhance performance in learning and memory task
37. The competitive NMDA antagonist, D-CPPene, potentiates the anticonvulsant activity of conventional antiepileptics against maximal electroshock-induced seizures in mice
38. The NMDA antagonist procyclidine, but not ifenprodil, enhances the protective efficacy of common antiepileptics against maximal electroshock-induced seizures in mice